跳至主要内容
临床试验/NCT03438682
NCT03438682已完成不适用

Real World Effectiveness and Safety of Hysteroscopic (Essure®) Compared to Laparoscopic Sterilization

Yale University1 个研究点 分布在 1 个国家目标入组 89,203 人开始时间: 2018年9月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
89,203
试验地点
1
主要终点
Effectiveness of hysteroscopic compared to laparoscopic sterilization and IUD placement (Aim 1a)

研究概览

简要总结

More than 345,000 U.S. women undergo either tubal ligation ("getting her tubes tied") or Essure procedures each year to permanently avoid pregnancy. Both prevent pregnancy by blocking women's Fallopian tubes but neither are 100% effective. Both can have complications, but not enough is known to help women make an informed choice between the two.

Essure is popular because it can be performed without anesthesia in a doctor's office and women can return to work the next day. However, patients have reported that the Essure procedure was unexpectedly painful. Also, women need to use other contraceptives for 3 months and then return for testing, to make sure their tubes are blocked and will prevent pregnancy. Not all women return for this test and some may get pregnant before realizing their Essure didn't work.

Essure was approved by the Food and Drug Administration (FDA) in 2002, but no studies ever compared it to tubal ligation. By 2015, over 9,000 women reported serious complications to the FDA. Women who were unhappy with Essure found each other online and created a Facebook "Essure Problems" support group that now has over 31,000 members. After an FDA Advisory Board expressed concerns about Essure's risks, in 2016 the FDA required stronger warnings about complications and announced that "more rigorous research" was needed, demanding Essure's maker conduct a new study comparing the benefits and risks of Essure to tubal ligation. Unfortunately, that study will not be finished before September 2023.

To provide answers as rapidly as possible for women considering sterilization, we will analyze data from the medical records of thousands of women with sterilization procedures funded by California's Medicaid. As poor women and women of color have different experiences with healthcare, and they more often choose sterilization, comparing these women's experiences with Essure and tubal ligation is very important. We will compare the safety and effectiveness of the 2 sterilization procedures to answer:

  • How many women got pregnant afterwards?
  • How many operations did each woman need to become infertile?
  • Which complications did women have (i.e. chronic pain, depression)? We will also check whether certain women (such as certain age groups or those with diabetes) were most likely to have problems after either procedure.

详细描述

Study Aims:

Aim 1. To compare the real world effectiveness of hysteroscopic sterilization, laparoscopic sterilization and intrauterine devices (IUDs) by calculating:

  1. Pregnancy rates at 3, 6, 12, 24, 36, 48, and 60 months post-procedure, indicating sterilization failure.
  2. Patient's ability to rely on sterilization after hysteroscopic sterilization (blocked tubes on hysterosalpingogram) compared to laparoscopic sterilization and IUDs at 3, 6, 12, 24, 36, 48, and 60 months post-procedure, indicating concern of sterilization failure.

Aim 2. To compare safety and complications after hysteroscopic sterilization laparoscopic sterilization, and IUD placement by:

  1. Evaluating rates of reoperation to achieve sterilization or reinsertion to achieve IUD placement at 3, 6, 12, 24, 36, 48, and 60 months post-procedure.
  2. Evaluating other outcomes suggested by patient partners, including additional surgeries due to complications, chronic pain, and/or depression, by measuring claims for narcotic prescriptions, and antidepressants at 3, 6, 12, 24, 36, 48, 60 months post-procedure (hysteroscopic sterilization, laparoscopic sterilization, or IUD placement).
  3. Identify sociodemographic and pre-sterilization clinical variables which may predict complications following hysteroscopic sterilization compared to laparoscopic sterilization and to IUDs.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women aged 18-50 years at the time of sterilization procedure
  • Claims indicating hysteroscopic or laparoscopic sterilization procedures or IUD placement

排除标准

  • Active cancer
  • Any conditions that would have excluded the patient for hysteroscopic sterilization
  • Any conditions that would have excluded the patient for laparoscopic sterilization

结局指标

主要结局

Effectiveness of hysteroscopic compared to laparoscopic sterilization and IUD placement (Aim 1a)

时间窗: Pregnancy rates at 60 months post-procedure

Pregnancy after sterilization or IUD placement, indicating failure

次要结局

  • Blocked fallopian tubes on post-procedure hysterosalpingogram test (Aim 1b)(60 months post-procedure)
  • Pre-procedure clinical variables associated with procedural complications(Up to 1-year pre-procedure)
  • Need for subsequent surgery to remove foreign body, remove fallopian tube(s) (salpingectomy), or uterus (hysterectomy)(60 months post-procedure)
  • Number of participants with new onset chronic pain as assessed by new prescriptions for narcotics(60 months post-procedure)
  • Reoperation to achieve sterilization or reinsertion to achieve IUD placement(60 months post-procedure)
  • Number of participants with new onset depression as assessed by new prescriptions for antidepressants(60 months post-procedure)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验